Antitumor activity of arsenite in combination with tetrandrine against human breast cancer cell line MDA-MB-231 in vitro and in vivo

BACKGROUND: Triple-negative breast cancer (TNBC) is one of the most difficult subtypes of breast cancer to treat due to its aggressive, metastatic behavior, and a lack of a targeted therapy. Trivalent arsenic derivatives (arsenite, As(III)) with remarkable clinical efficacy in acute promyelocytic le...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Bo, Yao, Mingjiang, Wang, Xiao, Sato, Ai, Okazaki, Ayane, Komuro, Hana, Hayashi, Hideki, Toyoda, Hiroo, Pei, Xiaohua, Hu, Xiaomei, Hirano, Toshihiko, Takagi, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090820/
https://www.ncbi.nlm.nih.gov/pubmed/30123091
http://dx.doi.org/10.1186/s12935-018-0613-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090820/
https://www.ncbi.nlm.nih.gov/pubmed/30123091
http://dx.doi.org/10.1186/s12935-018-0613-0

Ejemplares similares